Sutro Biopharma, Inc.
STRO
$30.52
$0.973.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.64% | -55.37% | -56.83% | -51.85% | -20.51% |
| Total Receivables | -7.95% | -53.84% | -41.07% | 15.09% | -56.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -78.17% | -68.98% | -2.51% | 75.64% | 147.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.12% | -56.04% | -55.12% | -47.77% | -18.94% |
|
|
|||||
| Total Current Assets | -23.12% | -56.04% | -55.12% | -47.77% | -18.94% |
| Net Property, Plant & Equipment | -42.35% | -39.91% | -29.82% | -24.98% | -21.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 106.36% | -83.15% | -89.31% | -84.40% | -85.70% |
| Total Assets | -24.72% | -55.11% | -53.60% | -46.35% | -20.32% |
|
|
|||||
| Total Accounts Payable | -32.95% | -27.78% | 13.16% | -29.21% | 8.91% |
| Total Accrued Expenses | -2.68% | 15.41% | -23.18% | 26.66% | 29.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.12% | 4.05% | 10.51% | 16.21% | 16.36% |
| Total Finance Division Other Current Liabilities | -70.31% | -81.74% | -67.43% | -84.57% | 112.79% |
| Total Other Current Liabilities | -70.31% | -81.74% | -67.43% | -84.57% | 112.79% |
| Total Current Liabilities | -46.78% | -43.03% | -45.24% | -42.88% | 67.33% |
|
|
|||||
| Total Current Liabilities | -46.78% | -43.03% | -45.24% | -42.88% | 67.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -55.75% | -49.66% | -45.07% | -41.12% | -36.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.69% | 14.47% | 12.35% | 11.42% | -1.91% |
| Total Liabilities | -11.05% | -10.60% | -12.83% | -12.59% | 13.71% |
|
|
|||||
| Common Stock & APIC | 13.45% | 1.69% | 2.22% | 2.97% | 16.94% |
| Retained Earnings | -17.80% | -24.28% | -30.34% | -31.35% | -39.70% |
| Treasury Stock & Other | -1,022.22% | -51.28% | -68.87% | 92.02% | 92.04% |
| Total Common Equity | -159.14% | -396.97% | -178.46% | -121.10% | -126.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -159.14% | -396.97% | -178.46% | -121.10% | -126.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -159.14% | -396.97% | -178.46% | -121.10% | -126.33% |
|
|
|||||